Gene-Edited Porcine Organ Transplantation Market

Kidney leads the organ type with 36.1% share in 2026, while CRISPR-Cas9 gene editing accounts for 37.2% of technology share and clinical organ transplantation represents 43.0% of application share. Demand reflects measurable graft outcomes, documented editing records, infection surveillance, immunosuppression protocols, and specialist hospital readiness.